Pneumonia News and Research

Latest Pneumonia News and Research

Study finds no benefit in using broad-spectrum antibiotics as initial pneumonia treatment

Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease.

26 Feb 2020

HKUST scientists provide leads for guiding research towards COVID-19 vaccine development

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.

26 Feb 2020

Studies analyze epidemiologic supervision and influenza cases among children in Catalonia

The viral infections of the upper respiratory tract are an important cause of morbidity and mortality worldwide and, among them, influenza is one of the most important ones, with severe cases ranging from three and five million cases, and between 290,000 and 650,000 deaths per year. This is why a proper supervision of the disease is crucial.

24 Feb 2020

New tool incorporates PET and CT scans to measure effectiveness of key anti-TB medicine

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.

24 Feb 2020

Researchers develop novel therapy to combat antibiotic-resistant superbug infections

There may be a solution on the horizon to combating superbug infections resistant to antibiotics. The tenacious bacteria and fungi sicken more than 2.8 million people and lead to more than 35,000 deaths in the United States each year.

20 Feb 2020

Coronavirus is deadlier than flu with seniors at highest risk

The novel coronavirus (CoV) is a new strain of coronavirus that has not been previously identified in humans. The new, or “novel” coronavirus, now called 2019-nCoV, had not previously detected before the outbreak was reported in Wuhan, China in December 2019.

19 Feb 2020

Study identifies new CoV responsible for the Wuhan outbreak

The 2019 novel coronavirus causes fatal pneumonia that has claimed over 1300 lives, with more than 52000 confirmed cases of infection by February 13, 2020, all in the span of just over a month.

18 Feb 2020

Potential method for better treatment of premature babies

A new study published in the journal Immunology in February 2020 reports the discovery of a process that occurs in the body naturally, but which enhances the production of type 3 innate lymphoid cells (ILCs) in the lung alveoli of premature babies. These are sentinel cells that keep the mucosal surfaces clean and healthy. They are crucial to building resistance to infection within the human body.

18 Feb 2020

Scientists may have a way to boost innate lung immunity in preterm babies

The continuing epidemic of pre-term birth includes this stark reality: tiny, fragile babies are born with underdeveloped lungs and prone to lifelong respiratory infections and related chronic illnesses.

18 Feb 2020

Measles re-emerging globally

Measles is a common childhood illness but can cause more than a passing fever with rash. It could turn out to be a complicated and severe illness, warn doctors in a new paper published in February 2020 in the journal BMJ Case Reports.

17 Feb 2020

Coronavirus outbreak deaths near 1,700

The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?

16 Feb 2020

China could be just the "tip of the iceberg" - Coronavirus

The coronavirus disease outbreak has rapidly spread in China and across the globe, with more than 1,400 deaths and 69,288 confirmed infections in seven weeks. Now, medical experts project that if the virus can not be contained, it can infect 60 percent of the population and kill 45 million people.

16 Feb 2020

Antibiotic resistance poses a growing risk during pandemics

Researchers investigating the drug prescription response to a "superbug" enzyme that renders bacteria resistant to antibiotics are available to discuss why such resistance is posing a growing risk during pandemics such as the current coronavirus.

14 Feb 2020

Facts vs. fears: Five things to help weigh your coronavirus risk

The news about the novel coronavirus in China grows more urgent daily. The number of related deaths is now greater than 1,300, while tens of thousands of people have been infected — most of them in China. People returning to the U.S. from China are quarantined for 14 days.

14 Feb 2020

Newly discovered antibiotics kill bacteria differently

Antibiotic resistance is a growing public health problem across the globe, with many diseases becoming harder to treat. Now, a newly discovered antibiotic group shows promise in the fight against superbugs as it has a unique way of killing bacteria.

13 Feb 2020

Coronavirus spread will remain under control and specific groups should not be stigmatized, urges microbiologist

As the global outbreak of coronavirus continues to dominate the headlines, a leading medical microbiologist from Kingston University says it is inevitable the United Kingdom will see more cases, but emphasized the spread of the virus will remain under control and called on people not to stigmatize particular communities.

13 Feb 2020

Study finds no evidence of intrauterine vertical transmission of COVID-19 infection

There is currently no evidence that the 2019 novel coronavirus disease (COVID-19) causes severe adverse outcomes in neonates or that it can pass to the child while in the womb, according to a small observational study of women from Wuhan, China, who were in the third trimester of pregnancy and had pneumonia caused by COVID-19.

12 Feb 2020

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital, the nation's leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases.

11 Feb 2020

Australian scientists grow live coronavirus virus

The novel coronavirus (2019-nCoV) is rapidly spreading across the globe, with the highest magnitude taking a toll on mainland China. Scientists are racing to find a vaccine or a treatment to help contain the virus spread. Now, a team of scientists and health experts in Australia may have found a breakthrough to fight the deadly virus.

11 Feb 2020

Coronavirus spread via aerosol raises concern as death toll rises

The Wuhan coronavirus or novel coronavirus (2019-nCoV) has started to spread in a seafood market in Wuhan China before New Year of 2019 and has since spread to 25 countries and has infected more than 40,000 people. The death toll has surpassed that of the SARS outbreak in 2002-2003, and new developments in the virus’s mode of transmission raise alarm worldwide.

10 Feb 2020